Us Bancorp \De\ Orchard Therapeutics PLC Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.42 - $0.78 $3,879 - $7,204	-9,236 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$0.7 - $1.51 $2,494 - $5,380	3,563 Added 62.81%	9,236 $7,000
Q4 2021 Feb 11, 2022	BUY	$1.16 - $2.23 $4,111 - $7,903	3,544 Added 166.46%	5,673 $7,000
Q3 2021 Nov 10, 2021	BUY	$2.24 - $4.29 $2,880 - $5,516	1,286 Added 152.55%	2,129 $5,000
Q2 2021 Aug 05, 2021	BUY	$4.39 - $7.23 $3,700 - $6,094	843 New	843 $4,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.